A Duchenne Muscular Dystrophy Drug Gains Patient Support

The staff of the Food and Drug Administration said a clinical trial for the drug, eteplirsen, was too small, but advocates said the drug prolonged patients’ ability to walk.

from NYT > Health http://ift.tt/1Ud6bOz
via health&fitness